Sign in / Join Now
ETFs & Funds
looking good today, new high on breakout. Any news?
Add a reply...
Latest StockTalks »
people get INCY breaking news and analysis by email alert.
Get email alerts on INCY »
Get latest price
From other sites
Pooled Analysis Of Five-Year Data From Two Phase 3 Studies Further Supports Overall Survival Advantage Observed In Patients With Myelofibrosis Treated With Jakafi® (ruxolitinib)
at TheStreet (Sun, 1:08PM)
New Oriental Education & Technology Group, BJ's Restaurants, ARIAD Pharmaceuticals, Incyte and Exelixis highlighted as Zacks Bull and Bear of the Day
at Zacks.com (Nov 18, 2016)
How Incyte Just Became A Major M&A Target
at Benzinga (Nov 17, 2016)
Increased Earnings Estimates Seen for Incyte (INCY): Can It Move Higher?
at Zacks.com (Nov 17, 2016)
Incyte Shares Jump After Gilead Misses With Myelofibrosis Competitor
at TalkMarkets (Nov 16, 2016)